Aryan Govil

Aryan Govil is the Co-Founder of Synaptrix Labs, where he is pioneering advancements in accessibility for individuals with severe motor impairments, such as paralysis and ALS. His innovative work focuses on developing brain-computer interface solutions and AI models designed to restore communication and mobility, offering these patients a renewed sense of independence and significantly improving their quality of life. Synaptrix Labs is dedicated to creating low-cost, user-friendly, and scalable devices that can make a meaningful impact on a global scale.

In addition to his entrepreneurial efforts, Aryan brings a wealth of medical research experience to the Neuro Health Alliance. As a Research Associate at the NYU Grossman School of Medicine, he investigated the connection between Type 2 Diabetes and Alzheimer's Disease through clinical trials, contributing to groundbreaking discoveries in neurodegenerative disease. His research background includes projects at Columbia University and UC Irvine, along with his role as a Scientific Editor at Grey Matters, a leading undergraduate neuroscience journal. Aryan has published abstracts on EEG signal analysis and classification, and he has developed AI models for MRI image segmentation.

A graduate of New York University with top honors in Neuroscience and Chemistry, Aryan's expertise and innovative mindset are invaluable assets to NHA’s mission to advance neuropsychiatry and improve mental health outcomes.